Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Helminth seropositivity in allergic bronchopulmonary aspergillosis: Co-exposure, misdiagnosis, or cross-reactivity?

Tropical doctor·2026

Same author

Yoga for Cancer Symptom Management: A Review of its Therapeutic Benefits on Breast Cancer, Quality of Life, and Psychological Distress.

International journal of yoga·2026

Same author

Strengthening Actions for Menstrual Health and Hygiene Interventions for Promotion of Women's Health in Nepal (SAMIP): Protocol for a Participatory Intervention Development Study Using Realist Synthesis, Human-Centered Design, Intervention Mapping, and Arts-Based Methods.

JMIR research protocols·2026

Same author

Hydrogels in regenerative wound therapy: A journey from basic polymers to smart platforms.

Annales pharmaceutiques francaises·2026

Same author

RanGAP1 accumulates in stress-induced cytoplasmic compartments that are distinct from stress granules and P-bodies.

microPublication biology·2026

Same author

Stability-centric Development of mRNA Vaccines: A Comprehensive Review of Design, Delivery, and Regulatory Considerations.

Reviews on recent clinical trials·2026

Search research articles

Related Experiment Video

Updated: Oct 2, 2025

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Targeting nanoparticles to malignant tumors.

Nikita Sharma¹, Kais Bietar¹, Ursula Stochaj¹

¹Department of Physiology, McGill University, Montreal, Quebec H3G 1Y6, Canada.

Biochimica Et Biophysica Acta. Reviews on Cancer

|March 1, 2022

Summary

Nanoparticles show promise for cancer theranostics, but efficient tumor targeting remains a challenge. Optimizing nanoparticle properties and administration routes is key for advancing nano-oncology in the clinic.

Keywords:

Cancer Nanomaterials Nanoparticle targeting Theranostics

More Related Videos

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Oct 2, 2025

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Area of Science:

Oncology
Nanotechnology
Biomedical Engineering

Background:

Nanomaterials, particularly nanoparticles, are crucial in modern health research.
Cancer theranostics offers significant potential for improved diagnostics and therapeutics.
Clinical translation of nanomedicine faces hurdles, primarily in targeted delivery.

Purpose of the Study:

To review nanoparticles developed for cancer detection and treatment.
To discuss barriers limiting nanoparticle accumulation in tumors.
To explore strategies for enhancing nanoparticle targeting in nano-oncology.

Main Methods:

Literature review focusing on nanoparticle properties and surface modifications.
Analysis of common and tissue-specific barriers to tumor accumulation.
Discussion of current limitations and future directions in nanoparticle-based cancer therapy.

Main Results:

Nanoparticle physicochemical properties and administration routes significantly influence targeting efficacy.
Surface modifications are critical for achieving efficient accumulation at tumor sites.
Understanding and overcoming biological barriers are essential for clinical success.

Conclusions:

Efficient nanoparticle targeting is paramount for effective cancer theranostics.
Further research into nanoparticle design and overcoming biological barriers is needed.
Advancing nano-oncology requires a focus on strategies that promote tumor-specific accumulation for clinical application.